These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 25583377)

  • 1. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Levels of Circulating Bone Morphogenetic Protein 7 Predict Mortality in Pulmonary Arterial Hypertension.
    Liu D; Wu BX; Sun N; Yan Y; Yuan P; Qu JM; Jing ZC
    Chest; 2016 Aug; 150(2):367-73. PubMed ID: 27001265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival in schistosomiasis-associated pulmonary arterial hypertension.
    dos Santos Fernandes CJ; Jardim CV; Hovnanian A; Hoette S; Dias BA; Souza S; Humbert M; Souza R
    J Am Coll Cardiol; 2010 Aug; 56(9):715-20. PubMed ID: 20723801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
    Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
    Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.
    Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of baseline characteristics and survival between patients with idiopathic and connective tissue disease-related pulmonary arterial hypertension.
    Ruiz-Cano MJ; Escribano P; Alonso R; Delgado J; Carreira P; Velazquez T; Sanchez MA; Sáenz de la Calzada C
    J Heart Lung Transplant; 2009 Jun; 28(6):621-7. PubMed ID: 19481024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
    Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
    Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct bilirubin: A new risk factor of adverse outcome in idiopathic pulmonary arterial hypertension.
    Xu XQ; Lv ZC; Liu QQ; Zhao QH; Wu Y; Sun K; Jiang X; Wang L; Peng FH; Jing ZC
    Int J Cardiol; 2017 Feb; 228():895-899. PubMed ID: 27894061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
    Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
    J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria.
    Douwes JM; van Loon RL; Hoendermis ES; Vonk-Noordegraaf A; Roofthooft MT; Talsma MD; Hillege HL; Berger RM
    Eur Heart J; 2011 Dec; 32(24):3137-46. PubMed ID: 21893489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension.
    Thenappan T; Glassner C; Gomberg-Maitland M
    Chest; 2012 Mar; 141(3):642-650. PubMed ID: 21885728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
    Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
    Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
    J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for connective tissue disease in pulmonary arterial hypertension.
    Pagán RJ; Lee AS; Austin CO; Burger CD
    South Med J; 2014 Oct; 107(10):666-9. PubMed ID: 25279875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.